Results 231 to 240 of about 135,935 (307)
Advances in deep brain stimulation for movement disorders. [PDF]
Zaib M, Khizar M, Ali Q, Mahato RK.
europepmc +1 more source
RT promotes VG161 replication in BC and its immunostimulatory transgenes expression, which is mediated by the upregulation of GADD34 and HVEM caused by RT. The combination therapy with VG161 and RT increases the abundances of tumor‐infiltrating lymphocytes and elicits potent systemic antitumor immunity, thereby effectively inhibiting local tumors and ...
Lijuan Lyu +13 more
wiley +1 more source
Proceedings of the 13th annual deep brain stimulation think tank: the evolving landscape. [PDF]
Fleeting CR +31 more
europepmc +1 more source
Sepsis‐associated encephalopathy (SAE) lacks effective therapies. We developed ME@FDsi, a biomimetic nanodrug using a tetrahedral framework nucleic acid to deliver disulfiram and siTNFα. It crosses the blood‐brain barrier, targets M1 microglia, inhibits pyroptosis and inflammation, and scavenges ROS.
Huimin Shi +15 more
wiley +1 more source
Real-Time ECG Artifact Removal for Adaptive Deep Brain Stimulation: A Comparative Study. [PDF]
Silvi L +5 more
europepmc +1 more source
Deep brain stimulation and obesity.
Mavridis, I., Anagnostopoulou, S.
openaire +2 more sources
Targeting Lilrb4a in Apolipoprotein E4 (APOE4)‐associated Alzheimer's disease (AD) reprograms microglia toward a beneficial, phagocytic state. Genetic deletion or antisense inhibition of Lilrb4a suppresses p‐SHP2/NF‐κB/STAT1 signaling, restores PPAR‐linked lipid and energy metabolism, and reduces amyloid plaque burden and cerebral amyloid angiopathy ...
Changxu Nie +12 more
wiley +1 more source
Predictors of deep brain stimulation response in patients with obsessive compulsive disorder: a systematic review and meta-analysis. [PDF]
Thavarajasingam SG +20 more
europepmc +1 more source

